< Resources

Webinar

Feb 27 | Leveraging Genomic Data to Transform Rare Cancer Treatment

Feb 28th is Rare Disease Day, a day dedicated to raising awareness of rare diseases, including rare cancers. These conditions are often overlooked compared to more commonly occurring cancers but did you know there are over 500 different rare cancers?


In the fight against cancer, understanding the genetic makeup is critical to developing personalized treatments that can make an actual difference in treating patients. A 2023 observational study1 presented in JAMA showed that only 6.8% underwent germline testing within two years of diagnosis. Furthermore, testing varied by cancer type, being the highest in males with breast cancer (50%) and in patients with ovarian cancer(38.6%). However, for many patients, especially those with rare cancer types, access to genomic sequencing, timely diagnosis and personalized care treatment protocols remain a significant challenge.


Join us during this time of rare disease awareness to explore how the Maine Cancer Genomics Initiative (MCGI) is revolutionizing cancer treatment for patients in rural and urban communities across Maine. Leveraging the data available in the Cancer Knowledgebase (CKB), MCGI enables clinicians to identify potential treatment options. CKB includes information on cancer related genes and variants, together with targeted therapies and clinical trials associated with genomic data. It also provides case study level data, based on national standardized guidelines thus equipping healthcare providers with the information they need to better understand rare cancer tumor types. Healthcare providers use these scientific and clinical insights to develop personalized treatment and improve outcomes for their patients.


In the webinar, we will discuss:  

 • How limited access to personalized treatment impacts patients with rare cancer types
 • Understand how Maine Cancer Genomics Initiative is using patients' genomic data, CKB and their collaboration to improve treatment outcomes
 • Discover how you can access a wealth of data to make more informed and targeted decisions, improving patient outcomes and quality of life.

Complete the form below to register:

Panelist
Cara Statz
Senior Clinical Analyst

Cara has nearly 10 years of experience in clinical genomics, and has been contributing her expertise to interpretation of literature-based data related to genomic variants and targeted therapies in oncology and curation of those data into the Cancer Knowledgebase (CKB) since 2015. In addition to her curation-related activities, Cara regularly liaises with users to provide additional insights into the capabilities of CKB. She received her PhD from UCONN in genetics and genomics and has prior experience as a clinical research associate, and leverages her clinical and research expertise in her work on CKB, with the ultimate goal of enabling better patient outcomes.

Panelist
Jens Reuter, MD

Dr. Rueter is the Chief Medical Officer at The Jackson Laboratory, Medical Director for the Maine Cancer Genomic Initiative, and the Associate Director for Translational Education at the JAX Cancer Center. As a member of the JAX Senior Management Team, he works with a number of JAX clinical genomics and education experts as well as several national leaders on advancing the field of Precision Medicine with the goal of individualizing cancer treatments for individual patients and improving their outcomes. Previously, Dr. Rueter was a Hematologist/Oncologist at EMMC Cancer and the Medical Director for EMMC Biobank and translational research in Brewer, Maine. After graduating from medical school in Berlin, Germany, Rueter completed his residency in internal medicine at Tulane University and Fellowship training in hematology/oncology at the University of Pennsylvania.

Moderator
Joe Jacher
Field Application Scientist

Joe provides technical support and training to Mastermind users at all levels. With a background as a clinical genetic counselor and in marketing and sales roles in the clinical laboratory space, he brings a patient-centric mindset to help end the diagnostic odyssey for patients globally.

The World’s Most Comprehensive Source of Genomic Evidence

Mastermind accelerates variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster

Create your free account
The Most Comprehensive Source of Curated Genomic Evidence + Scientific Experts

We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.